← Leaderboards
Alfred M Prince
New York Blood Center
$1,990,873
Attributed
$1,990,873
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,990,873 · 1
By mechanism
R01$1,990,873 · 1
Top collaborators
No co-investigators on record.
Most similar at New York Blood Center
Same institution · by research overlap
- Sara Lustigman$21,771,096
- Karina Yazdanbakhsh$18,887,767
- Raina N Fichorova$12,015,561
- Shibo Jiang$8,062,102
- Lanying Du$16,789,459
Others in their field
Top investigators on “Active Immunization”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$466,593,725
- Judith S. Currier · University Of California Los Angeles$322,872,111
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$256,197,143
- Daniel R Kuritzkes · Brigham And Women'S Hospital$217,875,923
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
Research focus
Active ImmunizationCellular ImmunityChimeric ProteinsCross ImmunityCytokineCytotoxic T LymphocyteHepatitis CHepatitis C VirusHumoral ImmunityImmunogeneticsNeutrophilPlasmidsPoxviridaeRecombinant DnaRecombinant ProteinsVaccine DevelopmentVector Vaccine
Grant awards (4)
PROPHYLACTIC &THERPEUTIC DNA IMMUNIZATION AGAINST HCV$527,244
R01 · FY2003 · AI
PROPHYLACTIC &THERPEUTIC DNA IMMUNIZATION AGAINST HCV$458,046
R01 · FY2002 · AI
PROPHYLACTIC &THERPEUTIC DNA IMMUNIZATION AGAINST HCV$496,980
R01 · FY2001 · AI
PROPHYLACTIC &THERPEUTIC DNA IMMUNIZATION AGAINST HCV$508,603
R01 · FY2000 · AI